Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,595 | -12,514 | -13,584 | -13,771 | -6,862 |
| Depreciation Amortization | 123 | 52 | 42 | 4,083 | 33 |
| Income taxes - deferred | -289 | 90 | -113 | -193 | 12 |
| Accounts payable and accrued liabilities | 226 | -808 | 783 | -311 | 137 |
| Other Working Capital | 3,666 | -1,822 | 669 | -1,036 | -321 |
| Other Operating Activity | 1,238 | 5,445 | 1,776 | 551 | -316 |
| Operating Cash Flow | $8,559 | $-9,557 | $-10,428 | $-10,675 | $-7,317 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | N/A | 6 | -64 | -20 |
| Net Acquisitions | N/A | N/A | N/A | -93 | -111 |
| Purchase Of Investment | -35,632 | 0 | N/A | N/A | N/A |
| Sale Of Investment | 12,976 | 0 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -114 |
| Investing Cash Flow | $-22,663 | $0 | $6 | $-157 | $-244 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 278 |
| Debt Repayment | N/A | N/A | N/A | -212 | N/A |
| Common Stock Issued | N/A | N/A | 8,117 | 17,795 | 5,218 |
| Common Stock Repurchased | N/A | N/A | -16 | N/A | N/A |
| Other Financing Activity | 15,498 | 5,966 | 520 | 0 | -499 |
| Financing Cash Flow | $15,498 | $5,966 | $8,621 | $17,583 | $4,998 |
| Exchange Rate Effect | -57 | 36 | -85 | -82 | -27 |
| Beginning Cash Position | 2,459 | 6,014 | 7,900 | 1,231 | 3,822 |
| End Cash Position | 3,796 | 2,459 | 6,014 | 7,900 | 1,231 |
| Net Cash Flow | $1,337 | $-3,555 | $-1,886 | $6,669 | $-2,591 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,559 | -9,557 | -10,428 | -10,675 | -7,317 |
| Capital Expenditure | -6 | N/A | N/A | -64 | -20 |
| Free Cash Flow | 8,553 | -9,557 | -10,428 | -10,739 | -7,337 |